Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BVMF/ABBV34 stock hub

BVMF/ABBV34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/ABBV34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.7T

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/ABBV34

In the news

Latest news · BVMF/ABBV34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.5

P25 11.3P50 14.6P75 19.6

Trailing P/E93

P25 15.2P50 21.5P75 27.3

ROEn/a

P25 5.3P50 12.3P75 22.5

ROIC22.8

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/ABBV34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

225

Groups with data

Currency

USD

Showing 225 of 225 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	57,000
Employees Change	2,000%
Employees Change Percent	3.64
Enterprise value	BRL 2.1T
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	BRL 1.7T
Price	BRL 61.98
Price currency	BRL
Rev Per Employee	5,749,288.56x
Sector	Healthcare
Sic	2836
Symbol	bvmf/ABBV34
Website	https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.08%
EV Earnings	109.59x
EV/EBIT	19.18x
EV/EBITDA	13.85x
EV/FCF	19.72x
EV/Sales	6.68x
FCF yield	5.98%
Forward P/E	13.5x
P/B ratio	-50.56x
P/E ratio	92.99x
P/S ratio	5.32x
PE Ratio10 Y	39.99x
PE Ratio3 Y	77.83x
PE Ratio5 Y	56.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.83%
EBITDA Margin	47.62%
FCF margin	31.81%
Gross margin	72.03%
Gross Profit	BRL 236B
Gross Profit Growth	11.06%
Gross Profit Growth Q	15.45%
Gross Profit Growth3 Y	3.97%
Gross Profit Growth5 Y	5.95%
Net Income	BRL 18.8B
Net Income Growth	-13.35%
Net Income Growth Q	-45.96%
Net Income Growth3 Y	-21.86%
Net Income Growth5 Y	-6.73%
Pretax Margin	9.51%
Profit Margin	5.79%
Profit Per Employee	BRL 329,020
ROA	10.03
Roa5y	8.68
ROCE	23.19
Roe5y	1,295.2
ROIC	22.83
Roic5y	22.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	19.88%
Cagr1y	-6.35%
Cagr3y	13.39%
Cagr5y	13.07%
Div CAGR10	29.27%
Div CAGR3	6.54%
Div CAGR5	6.19%
EPS Growth	-13.24
EPS Growth Q	-46.25
EPS Growth3 Y	-21.78
EPS Growth5 Y	-6.98
FCF Growth	29.87%
FCF Growth Q	154.57%
FCF Growth3 Y	-5.29%
FCF Growth5 Y	2.35%
OCF Growth	29.41%
OCF Growth Q	134.19%
OCF Growth10 Y	10.14%
OCF Growth3 Y	-4.32%
OCF Growth5 Y	2.62%
Revenue Growth	9.5x
Revenue Growth Q	12.43x
Revenue Growth3 Y	3.45x
Revenue Growth5 Y	4.59x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.46
Assets	BRL 711.9B
Cash	BRL 49B
Current Assets	BRL 164.8B
Current Liabilities	BRL 206.9B
Debt	BRL 380.4B
Debt EBITDA	BRL 2.41
Debt FCF	BRL 3.65
Equity	BRL -34.5B
Interest Coverage	7.52
Liabilities	BRL 746.4B
Long Term Assets	BRL 547.1B
Long Term Liabilities	BRL 539.5B
Net Cash	BRL -331.4B
Net Cash By Market Cap	BRL -19
Net Debt EBITDA	BRL 2.12
Net Debt FCF	BRL 3.18
Tangible Book Value	BRL -485.7B
Tangible Book Value Per Share	BRL -275
WACC	5.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.8
Inventory Turnover	3.67
Net Working Capital	BRL -50.2B
Quick ratio	0.52
Working Capital	BRL -44.7B
Working Capital Turnover	BRL -37.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.04%
Dividend Growth	-0.7%
Dividend Growth Years	6%
Dividend per share	BRL 1.51
Dividend Years	11
Dividend Yield	2.44%
Ex Div Date	2026-04-14
Last Dividend	BRL 0.38
Payout Frequency	Quarterly
Payout Ratio	325.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	512.6%
1Y total return	-6.35%
200-day SMA	72.26
3Y total return	45.81%
50-day SMA	68.37
50-day SMA vs 200-day SMA	50under200
5Y total return	84.83%
All Time High	81.36
All Time High Change	-23.82%
All Time High Date	2025-10-01
All Time Low	11.7
All Time Low Change	429.83%
All Time Low Date	2017-02-14
ATR	2.62
Beta	0.31
Ch YTD	-21.42
High	62.52
High52	81.36
High52 Date	2025-10-01
High52ch	-23.82%
Low	61.27
Low52	58.81
Low52 Date	2026-04-29
Low52ch	5.39%
Ma50ch	-9.35%
Price vs 200-day SMA	-14.22%
RSI	41.78
RSI Monthly	44.97
RSI Weekly	33.57
Sharpe ratio	-0.07x
Sortino ratio	0.05
Total Return	2.4%
Tr YTD	-20.55
Tr1m	-5.64%
Tr1w	-4.26%
Tr3m	-13.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 114.1B
Operating Income Growth	20.85
Operating Income Growth Q	18.82
Operating Income Growth3 Y	0.72
Operating Income Growth5 Y	5.79
Operating margin	34.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,763,680,450%
Net Borrowing	12,909,603,400
Shares Insiders	0.07%
Shares Institutions	76.02%
Shares Qo Q	0%
Shares Yo Y	0.04%
Short Ratio	3.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 99.1B
Average Volume	4,085.1x
Bv Per Share	-19.65
CAPEX	BRL -6.5B
Ch10y	352.8
Ch1m	-6.2
Ch1w	-4.26
Ch1y	-8.34
Ch3m	-14
Ch3y	35.68
Ch5y	63.11
Ch6m	-15.35
Change	-4.6%
Change From Open	-0.67
Close	64.97
Days Gap	-3.96
Depreciation Amortization	39,490,511,200
Dollar Volume	3,008,323.3
Earnings Date	2026-04-29
EBIT	BRL 114.1B
EBITDA	BRL 156.1B
EPS	BRL 10.59
F Score	8
FCF	BRL 104.2B
FCF EV Yield	5.07x
Financing CF	-55,020,798,575
Fiscal Year End	December
Founded	2,012
Goodwill	174,798,094,000
Income Tax	BRL 12.2B
Investing CF	-33,814,811,450
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2022-11-21
Last Split Type	Forward
Lynch Fair Value	BRL 3.33
Lynch Upside	-94.62
Ma150	73.02
Ma150ch	-15.12%
Ma20	64.44
Ma20ch	-3.82%
Net CF	21,993,712,600
Open	62.4
P FCF Ratio	16.73
P OCF Ratio	15.75
Payment Date	2026-05-21
Position In Range	56.8
Ppne	27,947,055,400
Price Date	2026-05-08
Price EBITDA	BRL 11.18
Relative Volume	14.8x
Revenue	327,709,447,775x
SBC By Revenue	1.57x
Share Based Comp	5,159,341,025
Tax By Revenue	3.72x
Tax Rate	39.06%
Tr6m	-14.41%
Volume	48,537
Z Score	2.29

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/ABBV34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.4%

$1.51 annual per share

Payout ratio

+325.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+6.2%

6 consecutive years of growth

Total shareholder yield

+2.4%

Next ex-dividend date: 2026-04-14

Performance

BVMF/ABBV34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/ABBV34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+76.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/ABBV34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.8

Neutral momentum band

Price vs 200-day MA

-14.2%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

-0.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/ABBV34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/ABBV34 stock rating?

bvmf/ABBV34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/ABBV34 analysis?

The full report lives at /stocks/bvmf/ABBV34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/ABBV34?

The latest report frames bvmf/ABBV34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/ABBV34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.